Deciphering preferential interactions within supramolecular protein complexes: The proteasome case

Molecular Systems Biology

Volumn 11, Issue 1, 2015, Pages

  Fabre, Bertrand ^a,b   Lambour, Thomas ^a,b   Garrigues, Luc ^a,b   Amalric, François ^a,b   Vigneron, Nathalie ^c,d,e   Menneteau, Thomas ^a,b   Stella, Alexandre ^a,b   Monsarrat, Bernard ^a,b   Van Den Eynde, Benoît ^c,d,e   Burlet Schiltz, Odile ^a,b   Bousquet Dubouch, Marie Pierre ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^d WELBIO ^*  (Belgium)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

affinity purification; correlation profiling; label free quantitative proteomics; mass spectrometry

Indexed keywords

GAMMA INTERFERON; GLYCEROL; PROTEASOME;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DENSITY GRADIENT; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN QUATERNARY STRUCTURE; PROTEOMICS; STOICHIOMETRY; SUPRAMOLECULAR CHEMISTRY; AFFINITY CHROMATOGRAPHY; GENE EXPRESSION PROFILING; HEK293 CELL LINE; LIQUID CHROMATOGRAPHY; METABOLISM; PROCEDURES; PROTEIN DOMAIN; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; U-937 CELL LINE;

EUKARYOTA;

CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOMICS; TANDEM MASS SPECTROMETRY; U937 CELLS;

EID: 84922933771     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.15252/msb.20145497     Document Type: Article

References (70)

1. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M, (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574
2. Andersen KM, Madsen L, Prag S, Johnsen AH, Semple CA, Hendil KB, Hartmann-Petersen R, (2009) Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome. J Biol Chem 284: 15246-15254
3. Basler M, Kirk CJ, Groettrup M, (2013) The immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol 25: 74-80
4. Beck F, Unverdorben P, Bohn S, Schweitzer A, Pfeifer G, Sakata E, Nickell S, Plitzko JM, Villa E, Baumeister W, Forster F, (2012) Near-atomic resolution structural model of the yeast 26S proteasome. Proc Natl Acad Sci USA 109: 14870-14875
5. Bousquet-Dubouch MP, Uttenweiler-Joseph S, Ducoux-Petit M, Matondo M, Monsarrat B, Burlet-Schiltz O, (2008) Purification and proteomic analysis of 20S proteasomes from human cells. Methods Mol Biol 432: 301-320
6. Bousquet-Dubouch MP, Baudelet E, Guerin F, Matondo M, Uttenweiler-Joseph S, Burlet-Schiltz O, Monsarrat B, (2009) Affinity purification strategy to capture human endogenous proteasome complexes diversity and to identify proteasome-interacting proteins. Mol Cell Proteomics 8: 1150-1164
7. Bousquet-Dubouch MP, Fabre B, Monsarrat B, Burlet-Schiltz O, (2011) Proteomics to study the diversity and dynamics of proteasome complexes: from fundamentals to the clinic. Expert Rev Proteomics 8: 459-481
8. Bouyssie D, Gonzalez de Peredo A, Mouton E, Albigot R, Roussel L, Ortega N, Cayrol C, Burlet-Schiltz O, Girard JP, Monsarrat B, (2007) Mascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: application to the proteomics study of membrane proteins from primary human endothelial cells. Mol Cell Proteomics 6: 1621-1637
9. Cascio P, (2014) PA28alphabeta: the enigmatic magic ring of the proteasome? Biomolecules 4: 566-584
10. Chapiro J, Claverol S, Piette F, Ma W, Stroobant V, Guillaume B, Gairin JE, Morel S, Burlet-Schiltz O, Monsarrat B, Boon T, Van den Eynde BJ, (2006) Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J Immunol 176: 1053-1061
11. Choi H, Kim S, Gingras AC, Nesvizhskii AI, (2010) Analysis of protein complexes through model-based biclustering of label-free quantitative AP-MS data. Mol Syst Biol 6: 385
12. Dahlmann B, Ruppert T, Kuehn L, Merforth S, Kloetzel PM, (2000) Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol 303: 643-653
13. Dick TP, Ruppert T, Groettrup M, Kloetzel PM, Kuehn L, Koszinowski UH, Stevanovic S, Schild H, Rammensee HG, (1996) Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86: 253-262
14. Drews O, Zong C, Ping P, (2007) Exploring proteasome complexes by proteomic approaches. Proteomics 7: 1047-1058
15. Fabre B, Lambour T, Delobel J, Amalric F, Monsarrat B, Burlet-Schiltz O, Bousquet-Dubouch MP, (2013) Subcellular distribution and dynamics of active proteasome complexes unraveled by a workflow combining in vivo complex cross-linking and quantitative proteomics. Mol Cell Proteomics 12: 687-699
16. Fabre B, Lambour T, Garrigues L, Ducoux-Petit M, Amalric F, Monsarrat B, Burlet-Schiltz O, Bousquet-Dubouch MP, (2014a) Label-free quantitative proteomics reveals the dynamics of proteasome complexes composition and stoichiometry in a wide range of human cell lines. J Proteome Res 13: 3027-3037
17. Fabre B, Lambour T, Garrigues L, Ducoux-Petit M, Amalric F, Monsarrat B, Burlet-Schiltz O, Bousquet-Dubouch MP, (2014b) Correction to "label-free quantitative proteomics reveals the dynamics of proteasome complexes composition and stoichiometry in a wide range of human cell lines". J Proteome Res 13: 6197-6198
18. da Fonseca PC, He J, Morris EP, (2012) Molecular model of the human 26S proteasome. Mol Cell 46: 54-66
19. Foster LJ, de Hoog CL, Zhang Y, Xie X, Mootha VK, Mann M, (2006) A mammalian organelle map by protein correlation profiling. Cell 125: 187-199
20. Gatto L, Vizcaino JA, Hermjakob H, Huber W, Lilley KS, (2010) Organelle proteomics experimental designs and analysis. Proteomics 10: 3957-3969
21. Gautier V, Mouton-Barbosa E, Bouyssie D, Delcourt N, Beau M, Girard JP, Cayrol C, Burlet-Schiltz O, Monsarrat B, Gonzalez de Peredo A, (2012) Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol Cell Proteomics 11: 527-539
22. Gingras AC, Gstaiger M, Raught B, Aebersold R, (2007) Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol 8: 645-654
23. Glatter T, Wepf A, Aebersold R, Gstaiger M, (2009) An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol 5: 237
24. Glickman MH, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428
25. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM, (1996) A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381: 166-168
26. Groettrup M, Kirk CJ, Basler M, (2010) Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol 10: 73-78
27. Guillaume B, Chapiro J, Stroobant V, Colau D, Van Holle B, Parvizi G, Bousquet-Dubouch MP, Theate I, Parmentier N, Van den Eynde BJ, (2010) Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci USA 107: 18599-18604
28. Guillaume B, Stroobant V, Bousquet-Dubouch MP, Colau D, Chapiro J, Parmentier N, Dalet A, Van den Eynde BJ, (2012) Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol 189: 3538-3547
29. Havugimana PC, Hart GT, Nepusz T, Yang H, Turinsky AL, Li Z, Wang PI, Boutz DR, Fong V, Phanse S, Babu M, Craig SA, Hu P, Wan C, Vlasblom J, Dar VU, Bezginov A, Clark GW, Wu GC, Wodak SJ, et al, (2012) A census of human soluble protein complexes. Cell 150: 1068-1081
30. Hernebring M, Fredriksson A, Liljevald M, Cvijovic M, Norrman K, Wiseman J, Semb H, Nystrom T, (2013) Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28. Sci Rep 3: 1381
31. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479
32. Kaake RM, Kao A, Yu C, Huang L, (2014) Characterizing the dynamics of proteasome complexes by proteomics approaches. Antioxid Redox Signal 21: 2444-2456
33. Khor B, Bredemeyer AL, Huang CY, Turnbull IR, Evans R, Maggi LB Jr, White JM, Walker LM, Carnes K, Hess RA, Sleckman BP, (2006) Proteasome activator PA200 is required for normal spermatogenesis. Mol Cell Biol 26: 2999-3007
34. Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madugundu AK, Kelkar DS, Isserlin R, Jain S, Thomas JK, Muthusamy B, Leal-Rojas P, Kumar P, Sahasrabuddhe NA, Balakrishnan L, Advani J, George B, Renuse S, Selvan LD, et al, (2014) A draft map of the human proteome. Nature 509: 575-581
35. Kirk R, Laman H, Knowles PP, Murray-Rust J, Lomonosov M, el Meziane K, McDonald NQ, (2008) Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor. J Biol Chem 283: 22325-22335
36. Kirkwood KJ, Ahmad Y, Larance M, Lamond AI, (2013) Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics 12: 3851-3873
37. Kish-Trier E, Hill CP, (2013) Structural biology of the proteasome. Annu Rev Biophys 42: 29-49
38. Klare N, Seeger M, Janek K, Jungblut PR, Dahlmann B, (2007) Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. J Mol Biol 373: 1-10
39. Kleijnen MF, Roelofs J, Park S, Hathaway NA, Glickman M, King RW, Finley D, (2007) Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites. Nat Struct Mol Biol 14: 1180-1188
40. Kristensen AR, Gsponer J, Foster LJ, (2012) A high-throughput approach for measuring temporal changes in the interactome. Nat Methods 9: 907-909
41. Lander GC, Estrin E, Matyskiela ME, Bashore C, Nogales E, Martin A, (2012) Complete subunit architecture of the proteasome regulatory particle. Nature 482: 186-191
42. Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, Unverdorben P, Beck F, Aebersold R, Sali A, Baumeister W, (2012) Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc Natl Acad Sci USA 109: 1380-1387
43. Lee KK, Sardiu ME, Swanson SK, Gilmore JM, Torok M, Grant PA, Florens L, Workman JL, Washburn MP, (2011) Combinatorial depletion analysis to assemble the network architecture of the SAGA and ADA chromatin remodeling complexes. Mol Syst Biol 7: 503
44. Li J, Horak KM, Su H, Sanbe A, Robbins J, Wang X, (2011a) Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest 121: 3689-3700
45. Li J, Powell SR, Wang X, (2011b) Enhancement of proteasome function by PA28α overexpression protects against oxidative stress. Faseb J 25: 883-893
46. Li X, Thompson D, Kumar B, Demartino GN, (2014) Molecular and cellular roles of PI31 (PSMF1) in regulation of proteasome function. J Biol Chem 289: 17392-17405
47. McCutchen-Maloney SL, Matsuda K, Shimbara N, Binns DD, Tanaka K, Slaughter CA, DeMartino GN, (2000) cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome. J Biol Chem 275: 18557-18565
48. Mouton-Barbosa E, Roux-Dalvai F, Bouyssie D, Berger F, Schmidt E, Righetti PG, Guerrier L, Boschetti E, Burlet-Schiltz O, Monsarrat B, Gonzalez de Peredo A, (2010) In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics 9: 1006-1021
49. Orlowski M, Wilk S, (2000) Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 383: 1-16
50. Osmulski PA, Hochstrasser M, Gaczynska M, (2009) A tetrahedral transition state at the active sites of the 20S proteasome is coupled to opening of the alpha-ring channel. Structure 17: 1137-1147
51. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, Davies KJ, (2010) The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432: 585-594
52. Raule M, Cerruti F, Benaroudj N, Migotti R, Kikuchi J, Bachi A, Navon A, Dittmar G, Cascio P, (2014) PA28alphabeta reduces size and increases hydrophilicity of 20S immunoproteasome peptide products. Chem Biol 21: 470-480
53. Romero P, Corradin G, Luescher IF, Maryanski JL, (1991) H-2Kd-restricted antigenic peptides share a simple binding motif. J Exp Med 174: 603-612
54. Ruschak AM, Kay LE, (2012) Proteasome allostery as a population shift between interchanging conformers. Proc Natl Acad Sci USA 109: E3454-E3462
55. Savulescu AF, Glickman MH, (2011) Proteasome activator 200: the heat is on. Mol Cell Proteomics 10: R110.006890
56. Schwarz K, Eggers M, Soza A, Koszinowski UH, Kloetzel PM, Groettrup M, (2000) The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition. Eur J Immunol 30: 3672-3679
57. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schroter F, Prozorovski T, Lange N, Steffen J, Rieger M, Kuckelkorn U, Aktas O, Kloetzel PM, Kruger E, (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624
58. Shimbara N, Nakajima H, Tanahashi N, Ogawa K, Niwa S, Uenaka A, Nakayama E, Tanaka K, (1997) Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells 2: 785-800
59. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ, (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5: 144-156
60. Stadtmueller BM, Hill CP, (2011) Proteasome activators. Mol Cell 41: 8-19
61. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K, (2000) Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 275: 14336-14345
62. Toes RE, Nussbaum AK, Degermann S, Schirle M, Emmerich NP, Kraft M, Laplace C, Zwinderman A, Dick TP, Muller J, Schonfisch B, Schmid C, Fehling HJ, Stevanovic S, Rammensee HG, Schild H, (2001) Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med 194: 1-12
63. Trinkle-Mulcahy L, Boulon S, Lam YW, Urcia R, Boisvert FM, Vandermoere F, Morrice NA, Swift S, Rothbauer U, Leonhardt H, Lamond A, (2008) Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 183: 223-239
64. Vizcaino JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Rios D, Dianes JA, Sun Z, Farrah T, Bandeira N, Binz PA, Xenarios I, Eisenacher M, Mayer G, Gatto L, Campos A, Chalkley RJ, Kraus HJ, Albar JP, Martinez-Bartolome S, et al, (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32: 223-226
65. Wang X, Huang L, (2008) Identifying dynamic interactors of protein complexes by quantitative mass spectrometry. Mol Cell Proteomics 7: 46-57
66. Wiese S, Gronemeyer T, Ofman R, Kunze M, Grou CP, Almeida JA, Eisenacher M, Stephan C, Hayen H, Schollenberger L, Korosec T, Waterham HR, Schliebs W, Erdmann R, Berger J, Meyer HE, Just W, Azevedo JE, Wanders RJ, Warscheid B, (2007) Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol Cell Proteomics 6: 2045-2057
67. Wilhelm M, Schlegl J, Hahne H, Moghaddas Gholami A, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, Mathieson T, Lemeer S, Schnatbaum K, Reimer U, Wenschuh H, Mollenhauer M, Slotta-Huspenina J, Boese JH, Bantscheff M, Gerstmair A, et al, (2014) Mass-spectrometry-based draft of the human proteome. Nature 509: 582-587
68. Zaiss DM, Standera S, Kloetzel PM, Sijts AJ, (2002) PI31 is a modulator of proteasome formation and antigen processing. Proc Natl Acad Sci USA 99: 14344-14349
69. Zaki N, Mora A, (2014) A comparative analysis of computational approaches and algorithms for protein subcomplex identification. Sci Rep 4: 4262
70. Zoeger A, Blau M, Egerer K, Feist E, Dahlmann B, (2006) Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cells. Clin Chem 52: 2079-2086